Absorption |
Blood-Brain Barrier | BBB+ | 0.9870 |
Human Intestinal Absorption | HIA+ | 0.9718 |
Caco-2 Permeability | Caco2+ | 0.8813 |
P-glycoprotein Substrate | Substrate | 0.7933 |
P-glycoprotein Inhibitor | Inhibitor | 0.6857 |
Inhibitor | 0.6352 |
Renal Organic Cation Transporter | Inhibitor | 0.7561 |
Distribution |
Subcellular localization | Lysosome | 0.3811 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7526 |
CYP450 2D6 Substrate | Substrate | 0.9334 |
CYP450 3A4 Substrate | Substrate | 0.5578 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8935 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9483 |
CYP450 2D6 Inhibitor | Inhibitor | 0.9622 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7980 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9166 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6784 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9662 |
Inhibitor | 0.7828 |
AMES Toxicity | Non AMES toxic | 0.9176 |
Carcinogens | Non-carcinogens | 0.9545 |
Fish Toxicity | High FHMT | 0.8253 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.7974 |
Honey Bee Toxicity | Low HBT | 0.7660 |
Biodegradation | Not ready biodegradable | 0.9921 |
Acute Oral Toxicity | II | 0.7604 |
Carcinogenicity (Three-class) | Non-required | 0.7464 |